PL3103784T3 - Wytwarzanie emulsji typu olej w wodzie zawierającej skwalen - Google Patents

Wytwarzanie emulsji typu olej w wodzie zawierającej skwalen

Info

Publication number
PL3103784T3
PL3103784T3 PL16176832T PL16176832T PL3103784T3 PL 3103784 T3 PL3103784 T3 PL 3103784T3 PL 16176832 T PL16176832 T PL 16176832T PL 16176832 T PL16176832 T PL 16176832T PL 3103784 T3 PL3103784 T3 PL 3103784T3
Authority
PL
Poland
Prior art keywords
squalene
manufacture
oil
water emulsion
emulsion
Prior art date
Application number
PL16176832T
Other languages
English (en)
Inventor
Maninder Hora
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44358794&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3103784(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL3103784T3 publication Critical patent/PL3103784T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C11/00—Aliphatic unsaturated hydrocarbons
    • C07C11/21—Alkatrienes; Alkatetraenes; Other alkapolyenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/10—Vacuum distillation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D3/00—Distillation or related exchange processes in which liquids are contacted with gaseous media, e.g. stripping
    • B01D3/14—Fractional distillation or use of a fractionation or rectification column
    • B01D3/143—Fractional distillation or use of a fractionation or rectification column by two or more of a fractionation, separation or rectification step
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/10—Wash bottles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00—Purification; Separation; Use of additives
    • C07C7/04—Purification; Separation; Use of additives by distillation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Clinical Laboratory Science (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
PL16176832T 2010-05-12 2011-05-12 Wytwarzanie emulsji typu olej w wodzie zawierającej skwalen PL3103784T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US39544810P 2010-05-12 2010-05-12
EP11738802.5A EP2569267B2 (en) 2010-05-12 2011-05-12 Improved methods for preparing squalene
EP16176832.0A EP3103784B1 (en) 2010-05-12 2011-05-12 Manufacture of an oil-in-water emulsion comprising squalene
EP13164769.5A EP2620423B2 (en) 2010-05-12 2011-05-12 Improved methods for preparing squalene
PCT/IB2011/001397 WO2011141819A1 (en) 2010-05-12 2011-05-12 Improved methods for preparing squalene

Publications (1)

Publication Number Publication Date
PL3103784T3 true PL3103784T3 (pl) 2019-07-31

Family

ID=44358794

Family Applications (4)

Application Number Title Priority Date Filing Date
PL13164769T PL2620423T5 (pl) 2010-05-12 2011-05-12 Ulepszone sposoby otrzymywania skwalenu
PL16176832T PL3103784T3 (pl) 2010-05-12 2011-05-12 Wytwarzanie emulsji typu olej w wodzie zawierającej skwalen
PL11738802T PL2569267T5 (pl) 2010-05-12 2011-05-12 Ulepszone sposoby otrzymywania skwalenu
PL19151232T PL3489211T3 (pl) 2010-05-12 2011-05-12 Ulepszone sposoby otrzymywania skwalenu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL13164769T PL2620423T5 (pl) 2010-05-12 2011-05-12 Ulepszone sposoby otrzymywania skwalenu

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL11738802T PL2569267T5 (pl) 2010-05-12 2011-05-12 Ulepszone sposoby otrzymywania skwalenu
PL19151232T PL3489211T3 (pl) 2010-05-12 2011-05-12 Ulepszone sposoby otrzymywania skwalenu

Country Status (20)

Country Link
US (5) US9199897B2 (pl)
EP (4) EP3103784B1 (pl)
JP (2) JP5946188B2 (pl)
KR (1) KR101875894B1 (pl)
CN (2) CN105125488A (pl)
AU (1) AU2011251706B2 (pl)
BR (1) BR112012028711B1 (pl)
CA (1) CA2798924C (pl)
EA (1) EA027142B1 (pl)
ES (4) ES2717266T3 (pl)
IL (1) IL222855A (pl)
MX (1) MX352758B (pl)
NZ (1) NZ603918A (pl)
PL (4) PL2620423T5 (pl)
PT (3) PT3489211T (pl)
SG (2) SG10201503689TA (pl)
SI (1) SI2569267T1 (pl)
TR (1) TR201905021T4 (pl)
WO (1) WO2011141819A1 (pl)
ZA (1) ZA201208381B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105125488A (zh) * 2010-05-12 2015-12-09 诺华股份有限公司 制备鲨烯的改良方法
EP3170508B1 (en) * 2010-06-04 2019-11-13 Wyeth LLC Vaccine formulations
AU2013229432A1 (en) 2012-03-08 2014-10-16 Novartis Ag Adjuvanted formulations of booster vaccines
BR112015005056A2 (pt) 2012-09-06 2017-11-21 Novartis Ag vacinas de combinação com sorogrupo b meningococcus e d/t/p
JP6440619B2 (ja) 2012-10-12 2018-12-19 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 混合ワクチン用の架橋されていない無細胞百日咳抗原
BR112015014250A2 (pt) 2012-12-18 2017-07-11 Glaxosmithkline Biologicals Sa método para imunizar um bebê, vacina de combinação e, kit
EP3052603B2 (en) * 2013-09-30 2023-08-09 AAK AB (publ) Enrichment of triterpene esters
US10238739B2 (en) 2014-12-02 2019-03-26 Novartis Ag Manufacture of surfactant-containing compositions with enhanced stability
AU2019281011A1 (en) * 2018-06-08 2021-01-28 Amyris, Inc. Synthesis of E,E-farnesol, farnesyl acetate and squalene from farnesene via farnesyl chloride
US12409221B2 (en) * 2018-12-24 2025-09-09 Grand Theravac Life Sciences (Nanjing) Co., Ltd. Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof
WO2023056089A1 (en) 2021-10-03 2023-04-06 Eisai R&D Management Co., Ltd. Immunological adjuvant formulations comprising tlr4 agonist e6020
CN113956125B (zh) * 2021-11-11 2022-10-11 宜春大海龟生命科学有限公司 一种植物角鲨烷的组合物及其制备方法和应用
WO2023250129A1 (en) * 2022-06-24 2023-12-28 Amyris, Inc. Compositions and methods for the purification of squalene
JP2025538826A (ja) 2022-12-12 2025-11-28 エボニック オペレーションズ ゲーエムベーハー 植物系スクアレンの調製方法
WO2025053947A1 (en) * 2023-09-07 2025-03-13 Avantor Performance Materials, Llc Synthetic triterpenes composition, method of production and applications thereof
US20250099365A1 (en) * 2023-09-25 2025-03-27 Mary Kay Inc. Cosmetic composition and uses thereof
WO2024261351A2 (en) 2024-05-08 2024-12-26 Vaccine Formulation Institute Ch Ltd. Immunologically active saponin fractions and adjuvant formulations

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060082A (en) 1976-08-16 1977-11-29 Mpl, Inc. Dual-ingredient medication dispenser
JPS57200142A (en) 1981-06-01 1982-12-08 Micron Kk Calculus removing tool
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
ES533744A0 (es) 1984-06-27 1985-05-01 Bendiberica Sa Mecanismo de direccion asistida compacto
JPH0348427A (ja) 1989-04-04 1991-03-01 Matsushita Electric Ind Co Ltd バイポーラ半導体装置とその製造方法
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
JPH0614756Y2 (ja) 1991-06-26 1994-04-20 株式会社アルテ 組み立て式の２室式容器兼用注射器
JPH06116171A (ja) 1992-10-06 1994-04-26 Nippon Fine Chem Co Ltd 天然スクワレンの精製方法
JP3484227B2 (ja) † 1994-05-20 2004-01-06 日清オイリオ株式会社 油脂からのスクワラン精製方法
US5496284A (en) 1994-09-27 1996-03-05 Waldenburg; Ottfried Dual-chamber syringe & method
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
AU3186297A (en) 1996-07-05 1998-02-02 Debiotech S.A. Dual-chamber syringe for mixing two substances prior to injection
US6090598A (en) * 1997-01-30 2000-07-18 Fuji Oil Company, Limited Enzymatic process for interesterification of fats and oils using distillation
GB9716578D0 (en) 1997-08-05 1997-10-08 Brf International Lipid removal
WO1999017820A1 (en) 1997-10-03 1999-04-15 Texas Pharmaceuticals, Inc. Improved dual chamber syringe apparatus
US5971953A (en) 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
US6165481A (en) * 1997-12-25 2000-12-26 Nippon Petrochemicals Company, Inc. Highly pure squalane, raw material for pharmaceuticals and cosmetics prepared by using the same and method for producing the same
DE19835749C1 (de) 1998-08-07 2000-02-03 Dieter Perthes Fertig-Spritze für nicht-stabile Arzneimittel
JP4282804B2 (ja) † 1998-12-24 2009-06-24 新日本石油株式会社 アジュバント組成物
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
MY142319A (en) * 2002-08-20 2010-11-15 Malaysian Palm Oil Board Mpob Extraction of palm vitamin e, phytosterols and squalene from palm oil
US20070092525A1 (en) * 2005-02-07 2007-04-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptide derived from gp41, a vaccine composition comprising said polypeptide, and uses for treating an infection by an hiv virus in an individual
DE60324794D1 (de) * 2003-09-04 2009-01-02 Biomay Ag Hypoallergene Polypeptide basierend auf aus Fisch gewonnenem Parvalbumin
US7208627B2 (en) * 2003-12-18 2007-04-24 Nippon Shokubai Co., Ltd Alkylborazine compound and production method for the same
EP1728528B1 (en) 2004-03-23 2013-06-19 Nipro Corporation Pre-filled syringe
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
US20090304742A1 (en) 2005-11-04 2009-12-10 Novartis Vaccines And Diagnostics Srl Influenza vaccines with reduced amount of emulsion adjuvant
CN101346152A (zh) * 2005-11-04 2009-01-14 诺华疫苗和诊断有限公司 用细胞培养物培养的流感病毒制备含非病毒颗粒抗原的佐剂疫苗
WO2007052059A2 (en) * 2005-11-04 2007-05-10 Novartis Vaccines And Diagnostics Srl Changing th1/th2 balance in split influenza vaccines with adjuvants
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
CN100376519C (zh) 2006-02-23 2008-03-26 华南农业大学 一种制备角鲨烯的方法
PT2086582E (pt) 2006-10-12 2013-01-25 Glaxosmithkline Biolog Sa Vacina compreendendo uma emulsão adjuvante óleo em água
GB0622282D0 (en) 2006-11-08 2006-12-20 Novartis Ag Quality control methods
ES2308924B1 (es) † 2007-05-18 2009-11-02 Pradomudo Investigacion Y Desarrollo, S.L(Titular El 50%) Procedimiento de obtencion de escualeno.
FR2933403B1 (fr) * 2008-07-07 2010-08-27 Sophim Procede d'extration de squalene, de stereols et de vitamine e contenus dans des condensats de raffinage physique et/ou dans des distillats de desodorisation d'huiles vegetales
WO2010023551A2 (en) * 2008-08-28 2010-03-04 Michael Broeker Production of squalene from hyper-producing yeasts
EP2396032B1 (en) † 2009-02-10 2016-09-28 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene
CN101597204B (zh) † 2009-07-09 2013-03-13 天津大学 以橄榄油为原料提取高纯度角鲨烯的方法
CN101697204B (zh) 2009-10-23 2013-02-20 北京派瑞根科技开发有限公司 电子签章
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506832B1 (en) 2009-12-03 2014-02-26 Novartis AG Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (en) 2009-12-03 2016-03-02 Novartis AG Circulation of components during homogenization and microfluidization of emulsions
CN105125488A (zh) * 2010-05-12 2015-12-09 诺华股份有限公司 制备鲨烯的改良方法
CN101830770B (zh) † 2010-06-02 2013-06-05 天津大学 从植物油脱臭馏出物中提取角鲨烯的方法
JP6116171B2 (ja) 2012-09-24 2017-04-19 株式会社ダスキン 左右開閉型払拭体保持具、払拭体及び清掃用具

Also Published As

Publication number Publication date
PT3103784T (pt) 2019-05-20
EP2569267B2 (en) 2017-03-22
EA027142B1 (ru) 2017-06-30
EP3103784A1 (en) 2016-12-14
KR101875894B1 (ko) 2018-08-02
US20160051670A1 (en) 2016-02-25
US9199897B2 (en) 2015-12-01
CA2798924A1 (en) 2011-11-17
ES2453316T5 (es) 2017-07-18
US20200061187A1 (en) 2020-02-27
EP2620423A1 (en) 2013-07-31
CA2798924C (en) 2014-05-06
TR201905021T4 (tr) 2019-05-21
US11077186B2 (en) 2021-08-03
NZ603918A (en) 2015-04-24
ES2597158T5 (es) 2020-03-26
US20130209510A1 (en) 2013-08-15
IL222855A (en) 2015-11-30
US9545440B2 (en) 2017-01-17
ES2453316T3 (es) 2014-04-07
US9867877B2 (en) 2018-01-16
MX2012013027A (es) 2012-12-17
CN102892734B (zh) 2015-07-22
IL222855A0 (en) 2012-12-31
AU2011251706A1 (en) 2012-12-20
EP3489211A1 (en) 2019-05-29
PL3489211T3 (pl) 2020-12-14
AU2011251706B2 (en) 2015-10-22
ES2717266T3 (es) 2019-06-20
BR112012028711B1 (pt) 2020-12-01
ZA201208381B (en) 2014-04-30
KR20130103668A (ko) 2013-09-24
WO2011141819A1 (en) 2011-11-17
US10517947B2 (en) 2019-12-31
ES2597158T3 (es) 2017-01-16
JP5946188B2 (ja) 2016-07-05
PL2620423T5 (pl) 2019-12-31
PT3489211T (pt) 2020-09-22
US20170072053A1 (en) 2017-03-16
MX352758B (es) 2017-12-07
SG10201503689TA (en) 2015-06-29
SG185419A1 (en) 2012-12-28
PT2620423T (pt) 2016-09-23
EP3489211B1 (en) 2020-07-15
EP2569267A1 (en) 2013-03-20
EP2620423B1 (en) 2016-07-20
EP2569267B1 (en) 2013-12-25
CN102892734A (zh) 2013-01-23
SI2569267T1 (sl) 2014-03-31
JP2013530941A (ja) 2013-08-01
ES2817446T3 (es) 2021-04-07
EP3103784B1 (en) 2019-02-06
EP2620423B2 (en) 2019-07-31
CN105125488A (zh) 2015-12-09
PL2569267T3 (pl) 2014-05-30
US20180169225A1 (en) 2018-06-21
PL2569267T5 (pl) 2017-10-31
BR112012028711A2 (pt) 2017-03-21
EA201291225A1 (ru) 2013-06-28
PL2620423T3 (pl) 2017-09-29
JP2015157858A (ja) 2015-09-03

Similar Documents

Publication Publication Date Title
PT3103784T (pt) Preparação de uma emulsão óleo-em-água que compreende esqualeno
PL2696839T3 (pl) Sposoby wytwarzania emulsji olej w wodzie
PL2761083T3 (pl) Papier i sposoby wytwarzania papieru
IL223089A0 (en) Role-based presentation views
EP2739221A4 (en) SURGICAL ANCHOR
PL2861800T3 (pl) Papier rozdzielający i sposób wytwarzania
EP2713872A4 (en) STEREOSCOPIC DERMATOSCOPE READY TO ROTATE AND INTERNET INTERFACE
PL2560616T3 (pl) Emulsja naśladująca łzy
ZA201108661B (en) Oil-in-water emulsion
ZA201307222B (en) Edible oil-in-water emulsion composition
GB201016900D0 (en) Emulsion
PT2621619E (pt) Processo de mistura
ZA201408755B (en) Edible oil-in-water emulsion
EP2662068A4 (en) OIL EMULSION COMPOSITION IN WATER
EP2644184A4 (en) OIL-IN-WATER EMULSION COMPOSITION
ZA201108660B (en) Oil-in-water emulsion
EP2906554A4 (en) SOLID FORMS OF NILOTINIB HYDROCHLORIDE
EP2609902A4 (en) PREPARATION OF A WATER IN OIL EMULSION COSMETICS
IL233697A0 (en) Theranostic methods and systems for the diagnosis and treatment of malaria
IL225300A0 (en) cyclosporine emulsion
EP2613200A4 (en) TONER AND MANUFACTURING METHOD THEREFOR
EP2697520A4 (en) Capsules with an emulsified syrup and preparation method therefor
EP2921163A4 (en) OIL-IN-WATER EMULSION COMPOUND
EP2829263A4 (en) OIL EMULSION COMPOSITION IN WATER
AP3134A (en) Emulsion explosives